Could lab-grown stem cells boost bone marrow transplant success?
NCT ID NCT07299123
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 24 times
Summary
This early-stage trial tests whether adding specially grown umbilical cord stem cells to a half-matched bone marrow transplant can improve outcomes for people with severe aplastic anemia, a rare condition where the bone marrow stops making enough blood cells. About 40 participants aged 6 to 60 will receive the stem cell infusion alongside their transplant. The main goal is to check safety, but researchers will also watch for graft-versus-host disease and survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE APLASTIC ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
28 Fuxing Road, Beijing, China.
Beijing, 100853, China
Conditions
Explore the condition pages connected to this study.